AMPH Amphastar Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
69.0%
Boa
14/14 critérios · 5a dados
Dados de Mercado
- P/L (Forward)
- 5.6
- P/L (Trailing)
- 9.6
- P/VP
- 1.12
- Market Cap
- $891.9M
- Enterprise Value
- $1.3B
Último Ano Fiscal
Dec 2025
- Receita
- $719.9M
- EBIT
- $149.1M
- EBITDA
- $212.3M
- FCO
- $156.1M
- FCF
- $119.0M
Histórico Anual
| Ano | Receita | EBIT | EBITDA | FCO | FCF |
|---|---|---|---|---|---|
| 2021 | — | — | — | — | — |
| 2022 | $499.0M | $117.9M | $146.2M | $89.2M | $65.1M |
| 2023 | $644.4M | $198.5M | $240.3M | $183.5M | $145.3M |
| 2024 | $732.0M | $220.1M | $277.3M | $213.4M | $172.3M |
| 2025 | $719.9M | $149.1M | $212.3M | $156.1M | $119.0M |
Quer uma análise mais profunda?
Nossos clientes recebem análises completas com valuation, tese de investimento e acompanhamento contínuo.
Falar com Especialista